Chips dominate both the short book and the options market today. Micron Technology reports Q4 results Wednesday after the close — and bears are already positioned. Micron tops the negative options flow table for the past week despite a 279% year-to-date gain. Advanced Micro Devices and NVIDIA sit alongside it in the bearish options rankings. Profit-taking via put hedges is the dominant pattern across all three names heading into quarter-end.
Meanwhile, Camtek — an Israeli chip equipment maker — is flashing a squeeze alert. ORTEX data shows utilisation at 97.9%, near its 52-week high. Available shares to borrow collapsed 73.7% in a single week to just 3.2%. That is a classic setup for a short squeeze if any positive catalyst arrives.
Achieve Life Sciences hit 100% utilisation today. Availability dropped to 1.13% — the lowest in 52 weeks. FDA clarity on cytisinicline is the trigger the market is watching. Any positive news could ignite a sharp move higher.
Lifecore Biomedical is being acquired by Webster Equity Partners in a deal worth up to $663.7M. Stockholders could receive up to $9.67 per share including milestone payments.
Earnings season cranks up this week. CarMax and Carnival Corporation both report Tuesday. Micron is Wednesday's headline act.
META drew a rare downgrade to Hold today. First Solar got the opposite — an upgrade with a consensus target of $276. Nike took another target cut, with six analysts now rating it a Sell. Citizens Financial Group had its price target trimmed to $89 by Morgan Stanley, though the Overweight rating held.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
